Digest Network Come funziona
Network
/
Società
bi
Non verificato

bioAffinity Technologies, Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaOncologiaSaluteScienza

69 comunicati stampa

Guarda tutti i comunicati
10/03/2026
Industria
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
Oncologia
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
03/03/2026
Eventi
Industria
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
Oncologia
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Industria
Medicina nucleare
Farmaceutica
Medicina - Varie
Oncologia
Attrezzature medico-sanitarie
Difesa / Forze Armate
Sanità
Biotecnologia
Scienza
Salute
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
19/02/2026
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
17/02/2026
Industria
Sanità
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
09/02/2026
Oncologia
Salute
Attrezzature medico-sanitarie
Medicina nucleare
Scienza
Biotecnologia
Mercato del lavoro
Industria
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
07/01/2026
Oncologia
Attrezzature medico-sanitarie
Salute
Medicina nucleare
Biotecnologia
Industria
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
03/12/2025
Eventi
Fiere
Industria
Attrezzature medico-sanitarie
Sanità
Biotecnologia
Medicina nucleare
Salute
Oncologia
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
14/11/2025
Scienza
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
Oncologia
Mercato azionario
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
Medicina - Varie
Industria
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0